Link: https://youtu.be/FRoQOzZRcpw

Duration: 115 min

Transcript: Download plain text

Short Summary

Dr. David — a 71-year-old neurologist and author of Brain Defenders whose own father died of Alzheimer's after five years of decline — joins host Steven to argue that dementia is largely a metabolic, mitochondrial and lifestyle problem rather than something cured by amyloid-targeting drugs. They trace the science from England's 1953 sugar-rationing cohort and birth-microbiome seeding through PPIs, head trauma and microglial switching, to debates on metformin, ketogenic flexibility, exercise and diet. The episode closes with a letter from his son Austin, Dr. David's "hope is not a strategy" creed, and a call to "reconnect."

Key Quotes

1. "Alzheimer's is primarily a metabolic condition of the brain." (00:00:26)
2. "genetics loads the gun. Lifestyle pulls the trigger." (00:01:01)
3. "we have offloaded agency of our brains to the pharmaceutical industry" (00:12:54)
4. "those who were the most active compared to those who were the least active had about a 45% risk reduction" (00:17:02)
5. "They found that the drugs basically have no meaningful effect in slowing the progression, much less leading to improvement." (00:22:40)

Detailed Summary

Brain Defenders: Microglia, Metabolism, and the Case Against Amyloid — Full Episode Summary

Episode overview: a "lifestyle over pharmacology" thesis

This long-form episode argues that Alzheimer's disease is substantially a metabolic and neuroinflammatory condition of the brain, and that upstream lifestyle variables — blood sugar, the gut microbiome, body fat, sleep, exercise, social connection and head-trauma history — sit farther upstream than beta-amyloid. The framing line repeated throughout is that genetics loads the gun and lifestyle pulls the trigger.

• The guests argue Alzheimer's is significantly preventable even though no treatment exists yet, and that the burden of proof therefore shifts to prevention starting decades earlier rather than to drug development.
• The central mechanistic claim is that all neurodegenerative diagnoses are united by disruption of the brain's immune system, which the second guest calls the huge a-ha in neuroscience today.
• The episode explicitly rejects the medical "party line" that beta-amyloid is the central player — people can carry heavy plaque loads without dementia symptoms — noting that roughly a third of Alzheimer's research focused on beta-amyloid ten years ago versus about 14% now.
• Prevention should start earlier, the way clinicians check blood lipids, blood pressure, activity and sleep before a heart attack rather than after; the host's practical starting point for an audience is people in their 30s and 40s, and Dr. David Pelato cites John Kennedy's line that "the time to fix the roof is when the sun is shining."

The guests: Dr. David Pelato and a second expert on microglial biology

Dr. David Pelato is an MD who completed a neurosurgery residency and is a board-certified neurologist who has seen thousands of brain scans; his father was a brain surgeon who developed Alzheimer's, and Pelato diagnosed him late — after obvious memory loss, losing things and disorientation — and says he would prescribe a medication for his own father if one existed.

• The second guest expert works on microglial biology, inflammation and metabolism; he has written a book (quoted at page 102), observed chocolate production in Peru, and says he has been interested in the genome/environment mismatch behind modern disease since age 15.
• That second expert's profile matches the Dr. David who joins the host for the back half of the episode: the age-15 letter to the editor of the Miami News, the book passage at page 102, the Peru chocolate observation, and the recorded stance in his own book that FDA-approved beta-amyloid drugs are ineffective and dangerous.
• The host, Stephen (called Steven in the later segment), is 34, and the episode frames that age group as the "perfect population" for the message because metabolism is still being formed — meaning people will wish they had known sooner.

The scale of the problem: mortality, prevalence and lifetime risk

In America, Alzheimer's is the third leading cause of death and about 7.6 million Alzheimer's patients live in the country, which anchors the episode's sense of urgency before it moves to mechanisms.

• If you live to age 85, the risk of developing dementia (generally Alzheimer's) is close to a flip of a coin, in the high 40% range; women have twice the risk of men.
• Cognitive problems can begin in a person's 60s or 70s, and Pelato invoked Benjamin Franklin's line that an ounce of prevention is worth a pound of cure.
• In a talk in Vancouver, British Columbia, he asked the audience to imagine being 85, then drew a line down the middle of the room to show half had been diagnosed with dementia — framing viewers as the arbiter of which half they end up in.

Alzheimer's as a metabolic disease of the brain

Pelato's framing is that changes in metabolism — blood sugar, blood pressure, body fat, blood lipids — are upstream of what makes a healthy brain go bad, rather than downstream effects of plaque accumulation.

• Dementia is an umbrella term for failure of cognitive function across multiple domains, with subtypes including Alzheimer's, vascular dementia, Lewy body dementia and frontotemporal dementia; most dementia is Alzheimer's.
• Some cognitive impairment is reversible, arising from medications or other medical problems, a caveat the episode raises alongside the prevention argument.
• Pelato openly disagrees with the beta-amyloid "party line" — "that is not reality" — on the grounds that heavy plaque loads can be present in people with no dementia symptoms.

Genetics: APOE, disclosure, and "genetics loads the gun"

The episode treats APOE status as a predisposition rather than a sentence, while pushing back on the old neurology practice of not disclosing APOE results to patients.

• APOE2 is associated with dramatic risk reduction and APOE3 is neutral, while about 25% of people carry APOE4 — roughly a fivefold (500%) higher Alzheimer's risk for one copy and up to a 12-fold (1,200%) increase for APOE44.
• Chris Hemsworth has been public about carrying two APOE4 alleles, the risk allele that about a quarter of people discover when they receive genome sequencing results.
• In the back-half segment, Dr. David says his own father did not carry APOE4 and that there are roughly 80 other genetic issues tied to Alzheimer's risk — hence his creed that genetics loads the gun and lifestyle pulls the trigger.
• Pelato's argument for disclosure is that APOE4 is a predisposition rather than a determinant, and that lifestyle can offset the genetic risk.

Exercise: the strongest evidence presented

A November 2025 JAMA study by an author named Marino used Framingham Heart Study participants — about 1,000 in each of three age groups (4,000 total: ages 25-44, 45-64 and 65-88) — followed for years, comparing dementia incidence with physical activity level.

• In middle-aged participants, the most physically active had about a 45% reduced risk of Alzheimer's disease versus the least active, in a disease the guest says has no meaningful treatment.
• Among older participants who carried APOE4, those who exercised the most had about a 67% reduced risk of becoming an Alzheimer's patient versus those who exercised the least.
• Exercise is described as a multi-tool: muscles act as an endocrine gland producing myokines that travel to the brain and stimulate BDNF (growing new brain cells and nurturing neurons and synapses); it improves insulin function, reduces inflammation, improves blood flow to the brain, and supports mitochondrial function.
• A recent meta-analysis concluded both aerobic activity and strength/resistance training are needed — strength to build muscle, aerobics for metabolic benefit — and muscle-building should start younger because it gets harder with age.
• Pelato argues doctors should teach patients to exercise rather than default to IV therapy every two weeks, and that while metformin does many of the same things as exercise, exercise does more.

The top five lifestyle list: agency, movement, connection and sleep

Pelato's ranked list puts agency first and frames the remaining items as equally weighted within the top five, with social connection and sleep anchoring the non-pharmacological entries.

• Number one is embracing being the architect of your own brain's destiny — Pelato argues nothing else matters without it, and that brain agency has been offloaded to the pharmaceutical industry and technology with nothing meaningfully effective to show for it.
• Number two is sedentarity, addressed through exercise as the multi-tool described above.
• Number three is lack of social connection; numbers four and five are non-restorative sleep — insufficient sleep or sleep of poor quality — with items three through five described as equally ranked.
• Supporting evidence for social connection comes partly from Blue Zones data on long-lived people with lower dementia risk, who had particular diets, lived in areas with lots of verticality (stairs) and were deeply embedded in community life.
• Connecting with others raises oxytocin, the "love hormone" secreted when people feel trust and connection, which stimulates supportive microglial cells.

Microglia: the core mechanism and the M2-to-M1 switch

Microglia are immune cells living within the brain, making up about 10% of the brain's cells and distinct from neurons, and the episode identifies their flip from supportive to destructive as the fundamental upstream event in Alzheimer's disease.

• Microglia were originally thought to be "glue" cells that held tissue together on dead slides, until live-tissue imaging showed them swimming around looking for something to repair or destroy.
• In the supportive M2 configuration, microglia have long arms, shore up the synapses connecting one neuron to the next, maintain the blood-brain barrier and keep neurons functioning healthily.
• The destructive M1 microglia is genetically identical — hence "evil twin" — and destroys synapses, so a person can no longer connect to other people, themselves or the world.
• Microglia are sensitive to metabolism and inflammation: when blood sugar is elevated, or inflammation from anywhere in the body reaches the brain (for example from a leaky gut), supportive microglia flip destructive.
• Energy metabolism dictates the switch: the supportive cell gets energy from active mitochondria producing ATP, while the destructive cell runs on glycolysis, so damaged mitochondria trigger the M2-to-M1 shift; mitochondrial function is sensitive to insulin, exercise and metformin.
• It is a feed-forward loop — destructive microglia downregulate their own mitochondrial function and secrete pro-inflammatory chemicals into the local brain environment that convert healthy microglia into activated "zombie" cells.
• TSPO PET scans show the Alzheimer's brain "lit up" with activation of brain immune cells versus a healthy control, and positive imaging is seen across a wide variety of neurodegenerative issues; because microglia can flip back to supportive, the direction of influence is under the individual's control.
• Brains of Alzheimer's patients show macroscopic atrophy — widened valleys between shrunken gyri and ventricles filled with spinal fluid — though the same appearance can result from hydrocephalus.
• M1 microglia are needed to destroy or neutralize acute injury or infection, but when they remain in the destructive configuration after the event has passed, recovery is delayed or never happens — a point Dr. David returns to in explaining why head trauma is so consequential.

Synaptic pruning and Alzheimer's as reactivated development

The episode's second guest argues that the same cells which prune synapses in normal infancy inappropriately destroy synapses in older adults, which can manifest as Alzheimer's.

• At age one the brain forms about 1 million synapses per second, with pruning/refinement happening at about 20% of that formation rate, and brains have more connections at age two than in adulthood; the host suggested this might explain kids' "terrible twos."
• Microglia are the mechanism that prune synapses in normal development, and there is a thinking in neuroscience that Alzheimer's is the reactivation of a normal developmental event — the brain "printing itself" inappropriately.
• Insufficient pruning is linked to autism spectrum disorder and Fragile X syndrome, termed hyperconnection syndromes.

Sleep and the glymphatic system

Restorative sleep is treated as a load-bearing variable, with the episode connecting it to memory consolidation, waste clearance, inflammation and next-day insulin function.

• Sleep can be measured formally via polysomnography in a lab, or estimated with consumer devices such as an Aura ring, Apple Watch or Whoop, which track heart rate, brain waves and blood oxygenation with reasonable reliability.
• Restorative sleep consolidates memories and experiences during REM, activates the glymphatic system to remove "garbage" (which new research indicates also happens when we move), reduces inflammation and improves insulin functionality.
• Even one night of poor sleep dramatically changes insulin function, has a significant effect on blood sugar control, sets the stage for degeneration, and significantly impairs decision-making the next day.
• The host described the glymphatic system as street cleaners sweeping the streets at night; the neuroscientist clarified they only come out during deep sleep, typically later in the night (around hour five and a half for him), with sleep cycles of roughly 90 minutes (60-90 depending on the person).

Decision-making: prefrontal cortex and amygdala

The episode links chronic inflammation directly to executive function, which is why lifestyle interventions are framed as brain interventions.

• The prefrontal cortex, located behind the forehead, occupies about one-third of the entire cortex and acts as the "adult in the room," exerting top-down control.
• The almond-shaped amygdala deep in the temporal lobe is sometimes called the "fear center" and produces impulsive, self-centered, rapid decisions.
• During the teenage years the prefrontal cortex takes control of the amygdala, enabling planning for the future and consideration of consequences for others and the planet — but inflammation can dramatically weaken that connection, so chronic inflammation degrades decision-making day in and day out.

Food, sugar and continuous glucose monitors

A live CGM demonstration and label-reading session make the abstract metabolic argument concrete, and the host's personal data produces some of the episode's surprises.

• The standard American diet became the Western diet and now a global diet aggressively featuring ultra-processed, pro-inflammatory foods, linking global nutrition to rising inflammation.
• In a live demonstration, 12 ounces of orange juice contained eight teaspoons of sugar and a can of soda would add two more teaspoons; the vitamin C and fiber do not offset the effect.
• CGMs are framed as personalized medicine showing how food affects blood sugar, which in turn affects the brain, heart and body.
• The host's own CGM data revealed cashews raised his blood sugar unexpectedly (causing him to overeat them) and that exercise produced a surprising though transient blood sugar elevation.
• CGMs are now available without a prescription in America after pushback; journal editorials claimed consumers would become neurotic about the data, and the host countered that if people shouldn't have their own data, they shouldn't be allowed to buy a bathroom scale — self-measurement beats annual fasting blood sugar checks.
• Consumer CGMs cost about $20 to $30 and are sold on Amazon and other retailers, either as finger-prick devices or continuous arm sensors that upload to a phone.
• Reading label data against his CGM, the host discovered barbecue sauce and balsamic glaze are 40-50% sugar, and that a commercial fat-free French dressing was 35% sugar — labels use tricks like "fat free" to mask sugar content.

Gluten: a disputed area

The episode handles gluten carefully, with the host and guest disagreeing about prevalence and the guest pointing out the confounders in self-reported gluten sensitivity.

• The host said roughly 1% of the world is truly gluten intolerant while about 20% of people, including him, buy gluten-free products; the guest disputed the 1% figure, noting non-celiac gluten sensitivity is a defined entity and far more common than full celiac disease.
• Reported prevalence cited: about 0.5% of the general population has non-celiac gluten sensitivity, celiac disease affects roughly 1%, 0.1% have a wheat allergy, and up to 20% of adults report feeling better on a gluten-free diet.
• Celiac is an autoimmune condition diagnosed via blood markers and small-bowel endoscopy.
• The guest cites Dr. Marius Hajivasalu at Sheffield Hospital, England, who described brain issues unrelated to celiac but linked to gluten consumption; one patient with lifelong headaches on narcotics went gluten-free for 6 weeks and became headache-free and off narcotics, until gastroenterologist Dr. Prutater proved by endoscopy that she lacked celiac hallmarks and told her to resume gluten — after which the headaches returned with a vengeance.
• Double-blind placebo-controlled food challenge trials show only a fraction of self-diagnosed individuals react specifically to gluten; confounders include fructans/fructose co-occurring with gluten, lower net carbohydrate or calories, and placebo effects.

Glyphosate, polyphenols and ultra-processed food

The second guest's food argument is framed less as single-nutrient avoidance than as a genome/environment mismatch, with processing as the culprit and polyphenols as the signal.

• Glyphosate is sprayed on non-GMO American wheat to desiccate it so it can be harvested faster, meaning even non-GMO wheat contains glyphosate residue; it affects bacteria as well as plants, has a significant effect on the gut microbiome, and is a mitochondrial toxin because mitochondria retain circular bacterial DNA.
• Polyphenols are chemicals read by gut bacteria, signaling them to increase antioxidant production; they also act as targeting molecules that activate the NRF2 pathway, increasing detoxification and antioxidant production and reducing inflammation.
• Coffee is identified as the number one source of polyphenols on the planet by consumption, ahead of berries and buckwheat; Himalayan tartary buckwheat is called one of the richest sources, and extra-virgin olive oil is also high.
• In America, 60% of the calories consumed by adults come from ultra-processed foods, processed so their polyphenols are stripped out and which by and large contain added sweeteners.
• For chocolate, the recommended threshold is north of 80% cocoa; while making chocolate in Peru, the guest observed a batch recipe of roughly 70% white sugar for white chocolate and about 50% for milk chocolate.
• The brain's drive to find sweet is described as a survival mechanism working through activation of uric acid, signaling that food in nature is not poisonous and helping the body store fat for winter; the traditional human and protohuman diet was rich in fiber and polyphenols with good levels of fat, contrary to the widely promoted low-fat trend.

Metabolic disease, Parkinson's and MPTP

Diabetes is presented as one of the strongest and most quantifiable lifestyle-linked risk multipliers for dementia and parkinsonism.

• For type 2 diabetes, some studies cited a 300% to 400% higher risk of Alzheimer's, but the guest says more recent data supports at least a 75% to 85% increased risk.
• Parkinson's disease risk is increased by about 85% in people with type 2 diabetes, the mechanism being activation of microglia that destroy the dopamine-producing substantia nigra; this brain evidence has been evident since the late 1980s.
• MPTP, a mitochondrial toxin, contaminated an IV designer drug at Stanford, and patients developed Parkinson's in a single day in the emergency room by having their dopamine-producing brain cells killed.
• MPTP became a standard research tool, used in laboratory mice at a conference the guest attended the previous week, and researchers have developed an offset in which giving mice RN60 (RNS60) prevented the microglial activation and damage.

Body fat, inflammation, alcohol and why women are at double risk

The episode treats inflammation as the common tissue connecting body fat, alcohol, air pollution and estrogen loss to the microglial switch.

• Body fat is an active organ that secretes pro-inflammatory cytokines rather than being inert calorie storage; being 30 lb over ideal body weight corresponds to about 30 lb of visceral fat surrounding organs.
• Inflammation is life-saving and necessary, but excessive acute inflammation (the cytokine storm in COVID) or lower-level inflammation sustained over long periods causes trouble; Alzheimer's is framed as a "cytokine drizzle" rather than a storm.
• Dementia risk was thought to follow a U-shaped curve with a sweet spot of one glass of wine per day for women and two for men, but reassessment indicates any alcohol consumption is probably not good for the brain.
• Alcohol is directly toxic to neurons and, like high blood sugar, inflammation, stress, sedentary living, lack of restorative sleep and social isolation, polarizes microglia from M2 into M1.
• Activated M1 microglia destabilize neurons and the blood-brain barrier and destroy synapses, so neuroscience now frames Alzheimer's as a "synaptopathy," a disease of lost synapses.
• The sharp post-menopause drop in estrogen, specifically estradiol, labels synapses with complement signaling molecules acting as "eat me" signals that recruit M1 microglia to destroy those synapses; Dr. Beth Stevens at Harvard demonstrated this complement "eat me" signal mechanism.
• Metabolic changes, inflammation and PM2.5 particles from wildfire are also known microglial activators.

40 Hz stimulation and gamma oscillation

A late segment presents sensory stimulation as a way of pushing microglia back toward the supportive phenotype — arguably the episode's most experimental claim.

• Dr. Leeway (Li) Sai at MIT demonstrated that the non-Alzheimer's brain has a background gamma (40 Hz) oscillation that is disrupted in the Alzheimer's brain.
• Flashing light at 40 times per second in Alzheimer's-model rodents restored the gamma rhythm and reverted microglial cells from the harmful state back to supportive; in animal models, one hour of daily 40 Hz light stimulation drove significant drops in plaque and tangle burden.
• 40 Hz light and 40 Hz sound stimulation has been applied to humans with Alzheimer's, restoring gamma oscillation and supportive microglial function, with interventional results better than any beta-amyloid-targeting drug; delivery is via strobe lighting, flickering LEDs or auditory clicks.
• Per page 102 of his book, microglia exposed to binge-level alcohol for 24 hours showed a 15% decrease in their ability to clear beta amyloid, and one night of non-restorative sleep reduces that clearance even more than binge drinking; beta amyloid is a player in Alzheimer's but not the pivotal one.
• In the same book the speaker states that FDA-approved beta-amyloid drugs are for the most part ineffective and significantly dangerous, and that his vote is they should not be used.

The back half begins: Dr. David, 71, and the view from his father's nursing home

Dr. David joins for a more personal, one-on-one segment anchored in his own family's experience of Alzheimer's.

• His practice sits directly across the parking lot from the nursing home where his father lived, so he could see his father's room from his examining room while meeting with other patients' families.
• His father, initially a "towering human," first denied his decline, offloaded blame and became accusatory — blaming people for moving things he could not find; from the first behavior change to his death took about five years.
• Dr. David believes the disease itself is what kills Alzheimer's patients, and says he would prescribe a medication for his own father if one existed.
• He became a grandfather at 71 and says this made him double down on his own health practices; he wants to be transparent with his grandchildren about his own foibles rather than only preaching what he does not do.
• At age 15 he wrote a letter to the editor of the Miami News arguing humans cannot adapt quickly enough to survive in a modern environment, describing people as "stuck with the outdated machinery" of pollution-resistant lungs, beer cans, concrete and shattering noise.
• His framing is captured by James Cameron's line that "hope is not a strategy": the goal is to give people an actionable strategy rather than offloading agency to hope for future cures.
• When asked what disease he fears most, the answer is Alzheimer's — not cancer or heart disease — because it means losing the ability to make one's own decisions and self-care; he calls patients' later unawareness of their decline a blessing, as he witnessed with his father.

Sugar, diet and the 1953 rationing cohort

The first major study discussed in the back half pushes the prevention window back before birth, using a natural experiment created by postwar scarcity.

• A newly published study followed a large cohort of women who conceived in England in 1953, when postwar sugar rationing was still in place, for 50-70 years; children whose mothers had no access to sugar during pregnancy and the first ~1,000 days had roughly a 40% reduced risk of Alzheimer's in old age.
• Responding to when prevention should begin, the host said his standard answer is that people need to pay attention in their 30s and 40s — the rationing study "really winds the clock back" much earlier than that.
• Dr. David proposed mechanisms the study itself did not address: sugar raises blood sugar, compromising brain function and even the genesis of the brain, and higher dietary sugar changes the array, function and diversity of gut bacteria and other organisms such as yeasts.

Seeding the microbiome at birth

The microbiome argument extends to the very first hours of life, with delivery method treated as a foundational variable.

• A baby has little microbiome until birth, and method of birth fundamentally shapes the newborn's microbiome: vaginal delivery "anoints" the baby with birth canal bacteria, viruses and yeasts in the eyes, nose and mouth, whereas a C-section newborn's microbiome is seeded by what was on the surgeon's glove.
• Research Dr. David believes is underway at NYU involves mothers who will have a C-section taking a swab of vaginal secretions before delivery, with the swab placed in the baby's nose and mouth afterward to restore a vaginal-type microbiome.
• He calls the microbiome–dementia link "quite profound": gut organisms make short-chain fatty acids important for brain function and secrete chemicals that change gene expression throughout the body, including the brain.

PPIs, gut leakiness, inflammation and microglia

Medications become a second-order lifestyle variable, linking the gut to the brain's immune switch.

• Acid-blocking proton pump inhibitors change gut pH, altering which organisms live there and their function, which can increase gut lining permeability ("leakiness") and set the stage for body inflammation whose inflammatory chemicals then travel into the brain.
• Inflammatory chemicals reaching the brain polarize the supportive M2 microglia into the destructive M1 phenotype.
• Microglial activation in living humans can be demonstrated with PET imaging using the TSPO receptor found on M1 microglia.

Head trauma: CTE, Muhammad Ali and Formula 1

Repeated head impacts are presented as a direct route into the same microglial failure, independent of blood sugar or genetics.

• Football players who repeatedly bang their heads develop encephalopathy/CTE, a progressive neurodegenerative condition that may ultimately kill them even after they stop playing, because the microglia that appropriately responded never revert to the supportive phenotype.
• Muhammad Ali's deteriorating speech and memory after boxing is called pugilistic parkinsonism, and any head bump — boxing to soccer — carries this risk, so protecting the head against trauma is essential.
• A study that came out the prior week looked at Formula 1 drivers as being at risk, and the first F1 driver to develop CTE made news about a week before the conversation.
• Outcomes of head trauma are much worse in people with pre-existing type 2 diabetes, because diabetes shifts microglia away from reverting to the supportive state and toward the destructive "evil twin" phenotype.

Mitochondria and the metformin debate

The metabolic pivot point of the whole episode is mitochondria, and metformin is the case study in whether a pill can substitute for behavior.

• Restoring mitochondrial function helps keep microglia in their supportive role, and both exercise and metformin can increase mitochondria in number and function and improve clearance of defective mitochondria; mitochondrial transplant techniques now exist for human hearts and are expected very soon into human brains.
• Metformin is being used in England as part of an Alzheimer's treatment protocol even though it is a diabetes drug that does not target beta-amyloid; the host asked whether the average person should be taking it.
• At a small healthspan/aging conference of about 20 people roughly eight years ago, when asked how many were taking metformin, about 80% of the scientists in the room raised their hands.
• The TAME trial, which would test metformin's effect on longevity and dementia, is being tried to start by Nir Barzilai at Albert Einstein but is stuck for funding because metformin is off patent; he estimates it is roughly a $70 million project.
• Current consensus is not to take metformin for generally healthy, non-diabetic people. First reason: it blunts exercise benefits, with multiple randomized controlled trials showing interference with exercise adaptations, even though exercise is described as the single most validated reproducible longevity intervention available.
• Second reason: risk of masking lifestyle fundamentals — intensive lifestyle modification consistently outperforms metformin in reducing cardiovascular risk, and a pill cannot replicate the systemic vascular and psychological benefits of movement, sleep and whole foods.
• The host added that the article they were reading did not mention the B12 deficiency seen in people taking metformin, and noted that Dr. David Sinclair recently published a paper ranking aging-clock interventions in which exercise led the list.
• For context, the trial protocol under discussion in England was funded by the UK government with £33 million (~$44 million) to test two medicines — metformin and an ADHD drug the transcript renders as "strata" — in about 1,000 people over 18 months; the British prime minister strongly favors the trial because his father died of dementia, and Pelato cites the inclusion of a metabolic drug as evidence the field has moved away from targeting beta amyloid.

Rejecting amyloid drugs and the lifestyle evidence

The episode's sharpest disagreement is with pharmacology, and it is supported by three specific studies and protocols.

• Dr. David says FDA-approved Alzheimer's drugs in the US are not the way to go and that he wrote in his last book he is not in favor of amyloid-targeting drugs because they are mostly ineffective and carry a significant risk profile.
• A newly published Cochrane analysis of amyloid-targeting Alzheimer's drugs looked at 20,342 individuals across 17 studies lasting 18 months each, and found the drugs have essentially no meaningful effect on slowing progression, much less producing improvement.
• A Harvard University study (Dean Rudolph Ornish) enrolled 51 people with Alzheimer's disease or mild cognitive impairment who increased exercise, changed diet, reduced stress and meditated an hour a day for 20 weeks; 70% of participants stabilized or improved rather than declining.
• The diet in that study was plant-forward and Mediterranean-type, rich in polyphenols and color, with attention to good fats and encouragement of social interaction; his practical advice is to watch blood sugar, get weight down, and use running shoes as a key tool.
• A newly published study from Havana, Cuba described an intra-arterial treatment of a kidney-made substance the transcript renders as "arithropoetin" that improved Alzheimer's patients by four points on a standard scale while the placebo group declined by four points; an intranasal description was cut off mid-sentence.

The ketogenic diet and brain energy

The ketogenic discussion is where the metabolic thesis is made quantitative, with energy-deficit numbers for the Alzheimer's brain.

• A ketogenic diet is defined as very low carbohydrate (less than about 50 grams of carbs per day) with added good fat such as extra-virgin olive oil, nuts and seeds.
• In clinical trials on mild cognitive impairment and early Alzheimer's, keto or ketone supplementation rescues roughly 10-18% of the brain's total energy supply and closes up to 80% of the fuel gap left by impaired glucose metabolism.
• That energetic boost translates into up to 15% improvement in standard memory and test scores and up to a 20% gain in daily functioning, helping patients manage basic self-care and everyday tasks with greater independence.
• The mechanism is metabolic: ketogenic diet plus exercise target mitochondrial function, and mitochondria are the pivot point determining supportive versus destructive microglia.
• When the brain becomes insulin resistant, the regions that suffer are the hippocampus (memory), hypothalamus (metabolism control), prefrontal cortex (decision-making and behavior) and olfactory bulb (smell) — the same functions that decline in Alzheimer's, making this an upstream energy deficiency rather than only a symptom.
• Matthew Phillips, a researcher in New Zealand, has published papers on the ketogenic diet in both Alzheimer's and Parkinson's, and Dr. David co-wrote a book chapter with him on using the ketogenic diet for Parkinson's.
• He advises against constant ketogenic dieting and instead recommends flexibility so a one- or two-day fast, or even a single very low-carb, higher-fat meal, enters ketosis quickly rather than taking a couple of weeks to adapt.
• Everything discussed about brain degeneration is equally valuable for brain performance, so the same measures apply to healthy people seeking optimal cognitive function.

Supplements and personal protocol

Dr. David closes the practical advice with his own regimen, tied to a genetic finding from his own testing.

• He has an MTHFR genetic quirk meaning he does not handle B vitamins well, leaving his homocysteine level elevated; homocysteine is described as a significant risk factor for heart disease and Alzheimer's.
• Because of his genetics he takes methylated B vitamins — a need he says likely applies to about 25% of the global population.
• He takes DHA from fish oil, getting about 1,000 mg of DHA per day.

Agency, legacy and the closing message

The final stretch is explicitly about reclaiming agency rather than waiting for a drug, and it ends with a family letter and a single-word instruction.

• Dr. David tells people not to put their faith in drugs and to make these changes today because they are hard; he wishes medicine would do these things but will not apologize, because that answers his first question about what he is doing: doing his best so others do not have to experience what he is feeling.
• He describes himself as a 71-year-old man who is not over what happened a long time ago and never will be — and says that is not a bad thing, because it motivates him and gives him courage to speak; if one person gets his message, he has done his job.
• He objects to hoping for a "wonder drug" — calling that hope inappropriate, wrong and "absolutely cruel" — and argues people need to regain agency.
• His son Austin's letter, read aloud on the podcast, says his father has been "an example of passion personified" for his patients, his family and the millions of people he reaches through podcasts; Austin is "filled with the joy to see [his father] become an exceptional grandfather," calls him "an incredible continuation of the work of your father," and signs off "Love from all of us across the pond."
• Host Steven describes being "in my lane" — having identified his skill set and exploiting it to the ends of the earth — and defines enlightenment as identifying your skill set and using it to contribute; he also cites the Dalai Lama's line about compassion for others' happiness and his own.
• At his father's eulogy Steven sang a Dan Fogelberg line — "my life has been a poor attempt to imitate the man... I'm just a living legacy to the leader of the band" — and made sure the attribution was correct.
• Dr. David asserts that "doctor" means teacher, not healer, and says the podcast is about teaching (for example whether to take creatine and at what dosage, what the research says, what the cause of aging is), framing it as curiosity married with compassion.
• His closing advice is "reconnect": reconnecting with others and relationships improves lives, brain health and the planet, and people must also reconnect with the planet.
• In Brainwash the authors define "disconnection syndrome" — microscopically the brain disconnected from the prefrontal cortex, macroscopically people disconnected from each other — and he notes the personal benefit of connection runs through oxytocin.
• The host noted his audience is especially keen to avoid dementia and Alzheimer's because it runs in their families, and that Brain Defenders offers a sense of agency and control over something that feels helpless; the book came out on August 27th, the day after Dr. David's birthday.
• The podcast tradition is that the last guest leaves a question for the next guest; breaking tradition by not hiding it from guests, the question sent for this guest was from Mark Hubin: "What makes you emotional?"

Notable takeaways and open threads

• Prevention is a decades-long upstream game — the 1953 rationing cohort suggests the window opens before birth, while the host's practical starting point is the 30s and 40s.
• The unifying mechanism proposed is metabolic: blood sugar, gut microbiome, inflammation, microglia phenotype and mitochondria all converge on upstream brain energy supply rather than on amyloid.
• The episode's sharpest disagreements are with pharmacology: amyloid-targeting drugs (Cochrane: no meaningful effect across 20,342 people) and routine metformin in healthy adults (blunts exercise adaptations, masks lifestyle fundamentals).
• Lifestyle remains the load-bearing intervention: Ornish's 51-patient Harvard study showed 70% stabilizing or improving over 20 weeks, and keto plus exercise are framed as tools for the same mitochondrial pathway.
• The most provocative claims left open for debate: abandoning amyloid-targeted drugs, the ethics of APOE disclosure, whether 40 Hz sensory stimulation can scale beyond small studies, and whether lifestyle advice can meaningfully offset a 5x-to-12x genetic risk.
• The unifying prescription from both halves: control blood sugar, exercise (aerobic plus strength), get restorative sleep, maintain relationships, eat a polyphenol-rich minimally processed diet, manage inflammation and body fat, protect the head, and treat alcohol as a brain toxin.